MDA SPACE LTD (MDA.CA) Stock Fundamental Analysis
TSX:MDA - Toronto Stock Exchange - CA55293N1096 - Common Stock - Currency: CAD
Taking everything into account, MDA scores 6 out of 10 in our fundamental rating. MDA was compared to 12 industry peers in the Aerospace & Defense industry. MDA has an excellent profitability rating, but there are some minor concerns on its financial health. MDA is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes MDA very considerable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year MDA was profitable.
In the past year MDA had a positive cash flow from operations.
Of the past 5 years MDA 4 years were profitable.
Each year in the past 5 years MDA had a positive operating cash flow.
1.2 Ratios
The Return On Assets of MDA (3.46%) is better than 91.67% of its industry peers.
Looking at the Return On Equity, with a value of 8.11%, MDA belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
MDA has a Return On Invested Capital (5.93%) which is comparable to the rest of the industry.
MDA had an Average Return On Invested Capital over the past 3 years of 3.99%. This is below the industry average of 8.10%.
The 3 year average ROIC (3.99%) for MDA is below the current ROIC(5.93%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.46% | ||
| ROE | 8.11% | ||
| ROIC | 5.93% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of MDA (8.06%) is better than 91.67% of its industry peers.
In the last couple of years the Profit Margin of MDA has grown nicely.
With a Operating Margin value of 10.38%, MDA perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Operating Margin of MDA has grown nicely.
MDA's Gross Margin of 24.84% is fine compared to the rest of the industry. MDA outperforms 66.67% of its industry peers.
In the last couple of years the Gross Margin of MDA has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.38% | ||
| PM (TTM) | 8.06% | ||
| GM | 24.84% |
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MDA is destroying value.
MDA has more shares outstanding than it did 1 year ago.
The debt/assets ratio for MDA has been reduced compared to a year ago.
2.2 Solvency
MDA has an Altman-Z score of 2.43. This is not the best score and indicates that MDA is in the grey zone with still only limited risk for bankruptcy at the moment.
With an excellent Altman-Z score value of 2.43, MDA belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
The Debt to FCF ratio of MDA is 0.17, which is an excellent value as it means it would take MDA, only 0.17 years of fcf income to pay off all of its debts.
MDA has a Debt to FCF ratio of 0.17. This is amongst the best in the industry. MDA outperforms 100.00% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that MDA is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.10, MDA is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 0.17 | ||
| Altman-Z | 2.43 |
ROIC/WACC0.63
WACC9.37%
2.3 Liquidity
A Current Ratio of 0.65 indicates that MDA may have some problems paying its short term obligations.
MDA has a worse Current ratio (0.65) than 83.33% of its industry peers.
A Quick Ratio of 0.64 indicates that MDA may have some problems paying its short term obligations.
With a decent Quick ratio value of 0.64, MDA is doing good in the industry, outperforming 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.65 | ||
| Quick Ratio | 0.64 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 120.00% over the past year.
Measured over the past years, MDA shows a very strong growth in Earnings Per Share. The EPS has been growing by 185.75% on average per year.
The Revenue has grown by 49.98% in the past year. This is a very strong growth!
Measured over the past years, MDA shows a very strong growth in Revenue. The Revenue has been growing by 31.32% on average per year.
EPS 1Y (TTM)120%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%163.64%
Revenue 1Y (TTM)49.98%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%67.86%
3.2 Future
MDA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.73% yearly.
MDA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.41% yearly.
EPS Next Y69.97%
EPS Next 2Y42.72%
EPS Next 3Y34.73%
EPS Next 5YN/A
Revenue Next Year50%
Revenue Next 2Y29.89%
Revenue Next 3Y23.41%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 49.34, MDA can be considered very expensive at the moment.
MDA's Price/Earnings is on the same level as the industry average.
MDA's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.54.
A Price/Forward Earnings ratio of 30.45 indicates a quite expensive valuation of MDA.
The rest of the industry has a similar Price/Forward Earnings ratio as MDA.
When comparing the Price/Forward Earnings ratio of MDA to the average of the S&P500 Index (36.44), we can say MDA is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 49.34 | ||
| Fwd PE | 30.45 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as MDA.
83.33% of the companies in the same industry are more expensive than MDA, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.4 | ||
| EV/EBITDA | 23.17 |
4.3 Compensation for Growth
MDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MDA has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as MDA's earnings are expected to grow with 34.73% in the coming years.
PEG (NY)0.71
PEG (5Y)N/A
EPS Next 2Y42.72%
EPS Next 3Y34.73%
5. Dividend
5.1 Amount
No dividends for MDA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:MDA (7/18/2025, 7:00:00 PM)
43.42
+1.61 (+3.85%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners30.22%
Inst Owner ChangeN/A
Ins Owners1.25%
Ins Owner ChangeN/A
Market Cap5.34B
Analysts76.67
Price Target38.19 (-12.05%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.13%
Min EPS beat(2)19.18%
Max EPS beat(2)21.08%
EPS beat(4)3
Avg EPS beat(4)21.89%
Min EPS beat(4)-9.44%
Max EPS beat(4)56.74%
EPS beat(8)7
Avg EPS beat(8)31.5%
EPS beat(12)10
Avg EPS beat(12)34.88%
EPS beat(16)13
Avg EPS beat(16)79.79%
Revenue beat(2)2
Avg Revenue beat(2)7.26%
Min Revenue beat(2)6.87%
Max Revenue beat(2)7.65%
Revenue beat(4)4
Avg Revenue beat(4)6%
Min Revenue beat(4)0.84%
Max Revenue beat(4)8.65%
Revenue beat(8)6
Avg Revenue beat(8)3.15%
Revenue beat(12)9
Avg Revenue beat(12)2.76%
Revenue beat(16)11
Avg Revenue beat(16)1.13%
PT rev (1m)7.4%
PT rev (3m)7.16%
EPS NQ rev (1m)12.55%
EPS NQ rev (3m)2.74%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0.52%
Revenue NQ rev (3m)0.95%
Revenue NY rev (1m)0%
Revenue NY rev (3m)16.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 49.34 | ||
| Fwd PE | 30.45 | ||
| P/S | 4.37 | ||
| P/FCF | 6.4 | ||
| P/OCF | 5.05 | ||
| P/B | 4.4 | ||
| P/tB | 28.46 | ||
| EV/EBITDA | 23.17 |
EPS(TTM)0.88
EY2.03%
EPS(NY)1.43
Fwd EY3.28%
FCF(TTM)6.79
FCFY15.64%
OCF(TTM)8.6
OCFY19.8%
SpS9.93
BVpS9.87
TBVpS1.53
PEG (NY)0.71
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.46% | ||
| ROE | 8.11% | ||
| ROCE | 8.23% | ||
| ROIC | 5.93% | ||
| ROICexc | 7.84% | ||
| ROICexgc | 65.94% | ||
| OM | 10.38% | ||
| PM (TTM) | 8.06% | ||
| GM | 24.84% | ||
| FCFM | 68.38% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
ROICexc(3y)4.25%
ROICexc(5y)N/A
ROICexgc(3y)14.8%
ROICexgc(5y)N/A
ROCE(3y)5.54%
ROCE(5y)N/A
ROICexcg growth 3Y59.28%
ROICexcg growth 5YN/A
ROICexc growth 3Y71.38%
ROICexc growth 5YN/A
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 0.17 | ||
| Debt/EBITDA | 0.55 | ||
| Cap/Depr | 237.75% | ||
| Cap/Sales | 18.19% | ||
| Interest Coverage | 6.47 | ||
| Cash Conversion | 479.99% | ||
| Profit Quality | 848.33% | ||
| Current Ratio | 0.65 | ||
| Quick Ratio | 0.64 | ||
| Altman-Z | 2.43 |
F-Score6
WACC9.37%
ROIC/WACC0.63
Cap/Depr(3y)234.8%
Cap/Depr(5y)169.15%
Cap/Sales(3y)23.53%
Cap/Sales(5y)18.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)120%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%163.64%
EPS Next Y69.97%
EPS Next 2Y42.72%
EPS Next 3Y34.73%
EPS Next 5YN/A
Revenue 1Y (TTM)49.98%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%67.86%
Revenue Next Year50%
Revenue Next 2Y29.89%
Revenue Next 3Y23.41%
Revenue Next 5YN/A
EBIT growth 1Y91.69%
EBIT growth 3Y76.57%
EBIT growth 5YN/A
EBIT Next Year177.81%
EBIT Next 3Y52.71%
EBIT Next 5YN/A
FCF growth 1Y975.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1100.79%
OCF growth 3Y124.48%
OCF growth 5YN/A